← All stocks

BMY vs PFE

Bristol-Myers Squibb Company Common Stock vs Pfizer Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

BMY
Bristol-Myers Squibb Company Common Stock
Healthcare
62.62
127.91B
PFE
Pfizer Inc. Common Stock
Healthcare
27.74
157.65B
ACCE scores
BMY
PFE
Composite score
Out of 100
78
58
Growth
64
19
Value
88
68
Quality
83
75
Momentum
77
70
Valuation
BMY
PFE
Price
62.62
27.74
Market cap
127.91B
157.65B
Trailing P/E
13.79
36.39
Forward P/E
9.65
9.49
EV / EBITDA
9.68
15.50
Dividend yield
4.0%
6.2%
Profitability
BMY
PFE
ROE
46.6%
5.0%
Net margin
18.9%
6.8%
Debt / equity
2.44
0.74
Free cash flow
12.85B
9.08B
Growth
BMY
PFE
Revenue growth (YoY)
5.7%
2.6%
Earnings growth (YoY)
1.5%
-10.1%
Analyst target
66.71
28.88
See full analysis